Stay updated on BOS for EoE Adolescents & Adults Clinical Trial
Sign up to get notified when there's something new on the BOS for EoE Adolescents & Adults Clinical Trial page.

Latest updates to the BOS for EoE Adolescents & Adults Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 2.15.1 to version 2.15.2.SummaryDifference0.1%
- Check14 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.1.SummaryDifference0.1%
- Check21 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information about Budesonide Oral Suspension (BOS) for Eosinophilic Esophagitis (EoE) and the addition of a new revision number. The collaborators' information remains consistent.SummaryDifference16%
- Check28 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 19, 2025.SummaryDifference0.3%
- Check36 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check43 days agoChange DetectedThe page has been updated to reflect a new last update date of March 25, 2025, replacing the previous estimated date of February 19, 2025.SummaryDifference0.1%
Stay in the know with updates to BOS for EoE Adolescents & Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BOS for EoE Adolescents & Adults Clinical Trial page.